Okoro, Kelechukwu U.Roby, Matthew D.Bankole, Adegbenga A.2018-04-302018-04-302018-03-15Kelechukwu U. Okoro, Matthew D. Roby, and Adegbenga A. Bankole, “Myocarditis Secondary to Mesalamine-Induced Cardiotoxicity in a Patient with Ulcerative Colitis,” Case Reports in Medicine, vol. 2018, Article ID 9813893, 3 pages, 2018. doi:10.1155/2018/9813893http://hdl.handle.net/10919/82941Development of cardiac manifestations in patients diagnosed with inflammatory bowel disease undergoing treatment with mesalamine is a rare. When this occurs, it can be difficult to tease out the primary etiology, as both IBD and mesalamine can cause cardiac manifestations independently of each other. The exact mechanism of mesalamine-induced cardiotoxicity is yet to be determined although several mechanisms have been described. We present the case of a gentleman with nonexertional chest pain in the setting of ulcerative colitis exacerbation believed to have occurred secondary to mesalamine.application/pdfenCreative Commons Attribution 4.0 InternationalArticle - Refereed2018-04-29Copyright © 2018 Kelechukwu U. Okoro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.https://doi.org/10.1155/2018/9813893